|
Volumn 166, Issue 1, 2003, Pages 195-196
|
PAPP-A, a novel marker of unstable plaque, is not influenced by hypolipidemic treatment in contrast to CRP [1]
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTILIPEMIC AGENT;
ATORVASTATIN;
C REACTIVE PROTEIN;
FENOFIBRATE;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
METALLOPROTEINASE;
PREGNANCY ASSOCIATED PLASMA PROTEIN A;
SOMATOMEDIN C;
TRIACYLGLYCEROL;
BIOLOGICAL MARKER;
HEPTANOIC ACID DERIVATIVE;
PYRROLE DERIVATIVE;
APHERESIS;
ATHEROSCLEROSIS;
ATHEROSCLEROTIC PLAQUE;
AUTOPSY;
CHOLESTEROL BLOOD LEVEL;
CORONARY ARTERY DISEASE;
DISEASE ASSOCIATION;
HEART INFARCTION;
HEART MUSCLE ISCHEMIA;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERLIPIDEMIA;
INFLAMMATORY CELL;
LETTER;
PRIORITY JOURNAL;
RISK FACTOR;
TRIACYLGLYCEROL BLOOD LEVEL;
UNSTABLE ANGINA PECTORIS;
VASCULAR SMOOTH MUSCLE;
BLOOD;
DRUG EFFECT;
ANTILIPEMIC AGENTS;
BIOLOGICAL MARKERS;
C-REACTIVE PROTEIN;
CORONARY DISEASE;
HEPTANOIC ACIDS;
HUMANS;
HYPERLIPIDEMIAS;
PREGNANCY-ASSOCIATED PLASMA PROTEIN-A;
PROCETOFEN;
PYRROLES;
|
EID: 0037211990
PISSN: 00219150
EISSN: None
Source Type: Journal
DOI: 10.1016/S0021-9150(02)00313-1 Document Type: Article |
Times cited : (11)
|
References (6)
|